Search

Search Constraints

You searched for: Author/Creator Qiu, Huawei

Search Results

1. 568 XTX201, a protein-engineered IL-2, exhibits tumor-selective activity in mice without peripheral toxicities in non-human primates. (9th November 2020)

2. 568 XTX201, a protein-engineered IL-2, exhibits tumor-selective activity in mice without peripheral toxicities in non-human primates. (9th November 2020)

3. Antibody Fc engineering for enhanced neonatal Fc receptor binding and prolonged circulation half-life. Issue 7 (3rd October 2019)

4. Engineered Fc-glycosylation switch to eliminate antibody effector function. Issue 1 (1st January 2020)

5. Engineering Aglycosylated IgG Variants with Wild-Type or Improved Binding Affinity to Human Fc Gamma RIIA and Fc Gamma RIIIAs. Issue 16 (4th August 2017)

8. Neoline, fuziline, songorine and 10-OH mesaconitine are potential quality markers of Fuzi: In vitro and in vivo explorations as well as pharmacokinetics, efficacy and toxicity evaluations. (1st March 2023)

9. Pharmacokinetics of novel Fc-engineered monoclonal and multispecific antibodies in cynomolgus monkeys and humanized FcRn transgenic mouse models. Issue 1 (1st January 2020)